Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Jan 4;63(1):2300337.
doi: 10.1183/13993003.00337-2023. Print 2024 Jan.

Genome-wide association study of preserved ratio impaired spirometry (PRISm)

Affiliations
Meta-Analysis

Genome-wide association study of preserved ratio impaired spirometry (PRISm)

Daniel H Higbee et al. Eur Respir J. .

Abstract

Background: Preserved ratio impaired spirometry (PRISm) is defined as a forced expiratory volume in 1 s (FEV1) <80% predicted and FEV1/forced vital capacity ≥0.70. PRISm is associated with respiratory symptoms and comorbidities. Our objective was to discover novel genetic signals for PRISm and see if they provide insight into the pathogenesis of PRISm and associated comorbidities.

Methods: We undertook a genome-wide association study (GWAS) of PRISm in UK Biobank participants (Stage 1), and selected single nucleotide polymorphisms (SNPs) reaching genome-wide significance for replication in 13 cohorts (Stage 2). A combined meta-analysis of Stage 1 and Stage 2 was done to determine top SNPs. We used cross-trait linkage disequilibrium score regression to estimate genome-wide genetic correlation between PRISm and pulmonary and extrapulmonary traits. Phenome-wide association studies of top SNPs were performed.

Results: 22 signals reached significance in the joint meta-analysis, including four signals novel for lung function. A strong genome-wide genetic correlation (rg) between PRISm and spirometric COPD (rg=0.62, p<0.001) was observed, and genetic correlation with type 2 diabetes (rg=0.12, p=0.007). Phenome-wide association studies showed that 18 of 22 signals were associated with diabetic traits and seven with blood pressure traits.

Conclusion: This is the first GWAS to successfully identify SNPs associated with PRISm. Four of the signals, rs7652391 (nearest gene MECOM), rs9431040 (HLX), rs62018863 (TMEM114) and rs185937162 (HLA-B), have not been described in association with lung function before, demonstrating the utility of using different lung function phenotypes in GWAS. Genetic factors associated with PRISm are strongly correlated with risk of both other lung diseases and extrapulmonary comorbidity.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: S.J. London reports support for the present work from National Institutes of Health (NIH), USA. M.H. Cho reports support for the present work from the National Heart, Lung, and Blood Institute (NHLBI) and grants from Bayer outside the submitted work. E. Wan reports grants from US Department of Veterans Affairs Research and Development, outside the submitted work. E. Silverman reports support for the present work from NIH (grant U01 HL089856) and has received institutional grant support from Bayer outside the submitted work. J.D. Crapo reports grants from NIH (U01 HL089897, U01 HL089856); and a leadership role as Chair of Board of Directors of COPD Foundation outside the submitted work. X. Hu reports support for the present manuscript from NIH/NHLBI (R01-HL153248), as well as travel support. L. Lahousse reports consulting fees from AstraZeneca and lecture honoraria from IPSA vzw and Chiesi, outside the submitted work. D.D. Sin reports lecture honoraria from GlaxoSmithKline, AstraZeneca and Boehringer Ingelheim, outside the submitted work. S.E. Harris reports support for the current manuscript from Biotechnology and Biological Sciences Research Council, and the Economic and Social Research Council (BB/W008793/1). M.D. Tobin, A.L. Guyatt and C. John have a funded research collaboration with Orion for collaborative research projects outside the submitted work. G. Davey Smith reports grants from MRC Integrative Epidemiology Unit at the University of Bristol (MC_UU_00011/1) and Scientific Advisory Board Membership for Relation Therapeutics and Insitro, outside the submitted work. M.D. Tobin reports support for the present work from Wellcome Trust, NIHR Leicester Biomedical Research Centre and National Institute of Health and Care Research, and has previously received funding from GlaxoSmithKline for collaborative research projects outside of the submitted work. J.W. Dodd declares he has received honoraria for participating in advisory boards and given lectures at meetings supported by GlaxoSmithKline, Boehringer Ingelheim, Chiesi, AstraZeneca, Fisher & Paykel and Aerogen; he has received sponsorship for attending international scientific meetings from Chiesi; he has also taken part in asthma clinical trials sponsored by Sanofi, AstraZeneca and Chiesi for which his institution received remuneration. All other authors have nothing to disclose.

Figures

FIGURE 1
FIGURE 1
Participant selection flow chart. BMI: body mass index; PRISm: preserved ratio impaired spirometry; GWAS: genome-wide association study.
FIGURE 2
FIGURE 2
Manhattan plot of discovery genome-wide association study after linkeage disequilibrium score regression filtering and adjustment.
FIGURE 3
FIGURE 3
Flow chart of single nucleotide polymorphisms (SNPs) analysed. GWAS: genome-wide association study; PRISm: preserved ratio impaired spirometry; LDSC: linkeage disequilibrium score regression; MAF: minor allele frequency; OR: odds ratio.

Comment in

References

    1. Stefano G, Duane LS, Claire V, et al. . Morbidity and mortality associated with the restrictive spirometric pattern: a longitudinal study. Thorax 2010; 65: 499–504. doi:10.1136/thx.2009.126052 - DOI - PMC - PubMed
    1. Wijnant SRA, De Roos E, Kavousi M, et al. . Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam Study. Eur Respir J 2020; 55: 1901217. doi:10.1183/13993003.01217-2019 - DOI - PubMed
    1. Wan ES, Fortis S, Regan EA, et al. . Longitudinal phenotypes and mortality in preserved ratio impaired spirometry in the COPDGene study. Am J Respir Crit Care Med 2018; 198: 1397–1405. doi:10.1164/rccm.201804-0663OC - DOI - PMC - PubMed
    1. Higbee DH, Granell R, Davey Smith G, et al. . Prevalence, risk factors, and clinical implications of preserved ratio impaired spirometry: a UK Biobank cohort analysis. Lancet Respir Med 2021; 10: 149–157. doi:10.1016/S2213-2600(21)00369-6 - DOI - PubMed
    1. Agusti A, Noell G, Brugada J, et al. . Lung function in early adulthood and health in later life: a transgenerational cohort analysis. Lancet Respir Med 2017; 5: 935–945. doi:10.1016/S2213-2600(17)30434-4 - DOI - PubMed

Publication types

MeSH terms

Grants and funding